Pure Global

DIAGAST Hema CQI - Indonesia BPOM Medical Device Registration

DIAGAST Hema CQI is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20209411858. The device is manufactured by DIAGAST. from France, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is PT. MEDQUEST JAYA GLOBAL.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
DIAGAST Hema CQI
Analysis ID: AKL 20209411858

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Manufacturer

DIAGAST.

Country of Origin

France

Authorized Representative

PT. MEDQUEST JAYA GLOBAL

AR Address

MENARA SALEMBA LT.6 ZONE 1, Jalan SALEMBA RAYA KAV.5-5A

Registration Date

Jun 10, 2024

Expiry Date

Aug 11, 2027

Product Type

Products used in the manufacture of blood preparations and preparations of origin and blood

Automated blood grouping and antibody test system.

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing